Skip to main content
SpringerLink
Log in

Use of Direct Oral Anticoagulants After Transcatheter Aortic Valve Replacement

  • Chapter
  • First Online:
Direct Oral Anticoagulants

  • 1014 Accesses

Abstract

Transcatheter aortic valve replacement (TAVR) is a well-established procedure which shares common features with percutaneous coronary intervention and surgical aortic valve replacement. Technical and clinical aspects influence the appropriate antithrombotic strategy. Anticoagulation management is a priority in patients with atrial fibrillation and may have a role in preventing bioprosthetic valve thrombosis. In this chapter, we will offer a summary of published studies, current recommendations, and future perspectives on optimal medical therapy after TAVR.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  • Baumgartner H, Falk V, Bax JJ, De Bonis M, Hamm C, Holm PJ, Iung B, Lancellotti P, Lansac E, Muñoz DR, Rosenhek R, Sjögren J, Tornos Mas P, Vahanian A, Walther T, Wendler O, Windecker S, Zamorano JL, Roffi M, Alfieri O, Agewall S, Ahlsson A, Barbato E, Bueno H, Collet JP, Coman IM, Czerny M, Delgado V, Fitzsimons D, Folliguet T, et al. 2017 ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2017;38:2739–86.

    Article  Google Scholar 

  • Chakravarty T, Søndergaard L, Friedman J, De Backer O, Berman D, Kofoed KF, Jilaihawi H, Shiota T, Abramowitz Y, Jørgensen TH, Rami T, Israr S, Fontana G, de Knegt M, Fuchs A, Lyden P, Trento A, Bhatt DL, Leon MB, Makkar RR, RESOLVE, SAVORY Investigators. Subclinical leaflet thrombosis in surgical and transcatheter bioprosthetic aortic valves: an observational study. Lancet. 2017;389(10087):2383–92. https://doi.org/10.1016/S0140-6736(17)30757-2. Epub 2017 Mar 19. PMID:28330690.

  • Chopard R, Teiger E, Meneveau N, Chocron S, Gilard M, Laskar M, Eltchaninoff H, Iung B, Leprince P, Chevreul K, Prat A, Lievre M, Leguerrier A, Donzeau-Gouge P, Fajadet J, Mouillet G, Schiele F, FRANCE-2 Investigators. Baseline characteristics and prognostic implications of pre-existing and new-onset atrial fibrillation after transcatheter aortic valve implantation: results from the FRANCE-2 Registry. JACC Cardiovasc Interv. 2015;8:1346–55.

    Article  Google Scholar 

  • Dangas GD, Tijssen JGP, Wöhrle J, Søndergaard L, Gilard M, Möllmann H, Makkar RR, Herrmann HC, Giustino G, Baldus S, de Backer O, Guimarães AHC, Gullestad L, Kini A, von Lewinski D, Mack M, Moreno R, Schäfer U, Seeger J, Tchétché D, Thomitzek K, Valgimigli M, Vranckx P, Welsh RC, Wildgoose P, Volkl AA, Zazula A, van Amsterdam RGM, Mehran R, Windecker S. A controlled trial of rivaroxaban after transcatheter aortic-valve replacement. N Engl J Med. 2020;382:120–9.

    Article  CAS  Google Scholar 

  • Ducci A, Pirisi F, Tzamtzis S, Burriesci G. Transcatheter aortic valves produce unphysiological flows which may contribute to thromboembolic events: an in-vitro study. J Biomech. 2016;49:4080–9.

    Article  Google Scholar 

  • Durko AP, Osnabrugge RL, Van Mieghem NM, Milojevic M, Mylotte D, Nkomo VT, Pieter KA. Annual number of candidates for transcatheter aortic valve implantation per country: current estimates and future projections. Eur Heart J. 2018;39:2635–42.

    Article  Google Scholar 

  • Feit F, Voeltz MD, Attubato MJ, Lincoff AM, Chew DP, Bittl JA, Topol EJ, Manoukian SV. Predictors and impact of major hemorrhage on mortality following percutaneous coronary intervention from the REPLACE-2 Trial. Am J Cardiol. 2007;100:1364–9.

    Article  Google Scholar 

  • Giustino G, Mehran R, Veltkamp R, Faggioni M, Baber U, Dangas GD. Neurological outcomes with embolic protection devices in patients undergoing transcatheter aortic valve replacement: a systematic review and meta-analysis of randomized controlled trials. JACC Cardiovasc Interv. 2016;9:2124–33.

    Article  Google Scholar 

  • Hansson NC, Grove EL, Andersen HR, Leipsic J, Mathiassen ON, Jensen JM, Jensen KT, Blanke P, Leetmaa T, Tang M, Krusell LR, Klaaborg KE, Christiansen EH, Terp K, Terkelsen CJ, Poulsen SH, Webb J, Bøtker HE, Nørgaard BL. Transcatheter aortic valve thrombosis: incidence, predisposing factors, and clinical implications. J Am Coll Cardiol. 2016;68:2059–69.

    Article  Google Scholar 

  • Hickey GL, Grant SW, Bridgewater B, Kendall S, Bryan AJ, Kuo J, Dunning J. A comparison of outcomes between bovine pericardial and porcine valves in 38 040 patients in England and Wales over 10 years. Eur J Cardiothorac Surg. 2015;47:1067–74.

    Article  Google Scholar 

  • Holmes DR, Brennan JM, Rumsfeld JS, Dai D, O’Brien SM, Vemulapalli S, Edwards FH, Carroll J, Shahian D, Grover F, Tuzcu EM, Peterson ED, Brindis RG, Mack MJ. Clinical outcomes at 1 year following transcatheter aortic valve replacement. JAMA. 2015;313:1019–28.

    Article  CAS  Google Scholar 

  • Jochheim D, Barbanti M, Capretti G, Stefanini GG, Hapfelmeier A, Zadrozny M, Baquet M, Fischer J, Theiss H, Todaro D, Chieffo A, Presbitero P, Colombo A, Massberg S, Tamburino C, Mehilli J. Oral anticoagulant type and outcomes after transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12:1566–76.

    Article  Google Scholar 

  • van Kesteren F, Wiegerinck EMA, Rizzo S, Baan J, Planken RN, von der Thüsen JH, Niessen HWM, van Oosterhout MFM, Pucci A, Thiene G, Basso C, Sheppard MN, Wassilew K, van der Wal AC. Autopsy after transcatheter aortic valve implantation. Virchows Arch. 2017;470:331–9.

    Article  Google Scholar 

  • Kiefer P, Gruenwald F, Kempfert J, Aupperle H, Seeburger J, Mohr FW, Walther T. Crimping may affect the durability of transcatheter valves: an experimental analysis. Ann Thorac Surg. 2011;92:155–60.

    Article  Google Scholar 

  • Kosmidou I, Liu Y, Alu MC, Liu M, Madhavan M, Chakravarty T, Makkar R, Thourani VH, Biviano A, Kodali S, Leon MB. Antithrombotic therapy and cardiovascular outcomes after transcatheter aortic valve replacement in patients with atrial fibrillation. JACC Cardiovasc Interv. 2019;12:1580–9.

    Article  Google Scholar 

  • Makkar RR, Blanke P, Leipsic J, Thourani V, Chakravarty T, Brown D, Trento A, Guyton R, Babaliaros V, Williams M, Jilaihawi H, Kodali S, George I, Lu M, McCabe JM, Friedman J, Smalling R, Wong SC, Yazdani S, Bhatt DL, Bax J, Kapadia S, Herrmann HC, Mack M, Leon MB. Subclinical leaflet thrombosis in transcatheter and surgical bioprosthetic valves: PARTNER 3 cardiac computed tomography substudy. J Am Coll Cardiol. 2020;75:3003–15.

    Article  Google Scholar 

  • Mangieri A, Montalto C, Poletti E, Sticchi A, Crimi G, Giannini F, Latib A, Capodanno D, Colombo A. Thrombotic versus bleeding risk after transcatheter aortic valve replacement: JACC review topic of the week. J Am Coll Cardiol. 2019;74:2088–101.

    Article  Google Scholar 

  • Mojoli M, Gersh BJ, Barioli A, Masiero G, Tellaroli P, D’Amico G, Tarantini G. Impact of atrial fibrillation on outcomes of patients treated by transcatheter aortic valve implantation: a systematic review and meta-analysis. Am Heart J. 2017;192:64–75.

    Article  Google Scholar 

  • Nijenhuis VJ, Brouwer J, Delewi R, Hermanides RS, Holvoet W, CLF D, Frambach P, De Bruyne B, van Houwelingen GK, Van Der Heyden JAS, Toušek P, van der Kley F, Buysschaert I, Schotborgh CE, Ferdinande B, van der Harst P, Roosen J, Peper J, Thielen FWF, Veenstra L, Chan Pin Yin DRPP, Swaans MJ, Rensing BJWM, Van’t Hof AWJ, Timmers L, Kelder JC, Stella PR, Baan J, ten Berg JM. Anticoagulation with or without clopidogrel after transcatheter aortic-valve implantation. N Engl J Med. 2020;382:1696–707.

    Article  CAS  Google Scholar 

  • Otto CM, Nishimura RA, Bonow RO, Carabello BA, Erwin JP 3rd, Gentile F, Jneid H, Krieger EV, Mack M, McLeod C, O’Gara PT, Rigolin VH, Sundt TM 3rd, Thompson A, Toly C. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary: a report of the american college of cardiology/american heart association joint committee on clinical practice guidelines. J Am Coll Cardiol. 2021;77(4):450–500. https://doi.org/10.1016/j.jacc.2020.11.035. Epub 2020 Dec 17. Erratum in: J Am Coll Cardiol. 2021;77(9):1276. PMID: 33342587.

  • Rodés-Cabau J, Masson JB, Welsh RC, Garcia del Blanco B, Pelletier M, Webb JG, Al-Qoofi F, Généreux P, Maluenda G, Thoenes M, Paradis JM, Chamandi C, Serra V, Dumont E, Côté M. Aspirin versus aspirin plus clopidogrel as antithrombotic treatment following transcatheter aortic valve replacement with a balloon-expandable valve: the ARTE (Aspirin Versus Aspirin + Clopidogrel Following Transcatheter Aortic Valve Implantation) randomized clinical trial. JACC Cardiovasc Interv. 2017;10:1357–65.

    Article  Google Scholar 

  • Ruff CT, Giugliano RP, Braunwald E, Hoffman EB, Deenadayalu N, Ezekowitz MD, Camm AJ, Weitz JI, Lewis BS, Parkhomenko A, Yamashita T, Antman EM. Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials. Lancet. 2014;383:955–62.

    Article  CAS  Google Scholar 

  • Saito Y, Nazif T, Baumbach A, Tchétché D, Latib A, Kaple R, Forrest J, Prendergast B, Lansky A. Adjunctive antithrombotic therapy for patients with aortic stenosis undergoing transcatheter aortic valve replacement. JAMA Cardiol. 2020;5:92–101.

    Article  Google Scholar 

  • Vranckx P, Windecker S, Welsh RC, Valgimigli M, Mehran R, Dangas G. Thrombo-embolic prevention after transcatheter aortic valve implantation. Eur Heart J. 2017;38:3341–50.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Cardiac, Thoracic, Vascular Sciences and Public Health, University of Padua Medical School, Padua, Italy

    Andrea Scotti, Mauro Massussi & Antonio Landi

  2. Department of Cardiology, Fondazione Policlinico A. Gemelli, Rome, Italy

    George Besis

Authors
  1. Andrea Scotti
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Mauro Massussi
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Antonio Landi
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. George Besis
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiac Rehabilitation Unit Ospedale, Sacra Famiglia Fatebenefratelli, Erba, Italy

    Riccardo Proietti

  2. McGill University, Montreal, QC, Canada

    Ahmed AlTurki

  3. Department of Pharmaceutical and Pharmacological Sciences, University of Padua, Padova, Italy

    Nicola Ferri

  4. Department of Medical Translational Sciences, University of Campania “Luigi Vanvitelli” - Monaldi Hospital, Naples, Italy

    Vincenzo Russo

  5. Division of Cardiology, Department of Internal Medicine, University of Utah School of Medicine, Salt Lake City, UT, USA

    T. Jared Bunch

Ethics declarations

The authors have no conflicts of interest to declare.

Disclaimer

None.

Rights and permissions

Reprints and permissions

Copyright information

© 2021 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Scotti, A., Massussi, M., Landi, A., Besis, G. (2021). Use of Direct Oral Anticoagulants After Transcatheter Aortic Valve Replacement. In: Proietti, R., AlTurki, A., Ferri, N., Russo, V., Bunch, T.J. (eds) Direct Oral Anticoagulants. Springer, Cham. https://doi.org/10.1007/978-3-030-74462-5_15

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-74462-5_15

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-74461-8

  • Online ISBN: 978-3-030-74462-5

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation